News - Seroquel


Current filters:


Popular Filters

DC Circuit Court says AstraZeneca not entitled to three-year exclusivity for Seroquel


In a brief opinion handed down last week by the US Court of Appeals for the District of Columbia Circuit,…

AstraZenecaNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel

Significant opportunity remains In unipolar depression market, says DR


Significant opportunity remains in the unipolar depression market owing to both the high prevalence of…

AbilifyGenericsMarkets & MarketingNeurologicalPharmaceuticalSeroquel

Slow-down of European bipolar therapy market set for short-term slowdown


Patent expiry of key blockbuster atypical antipsychotic drugs is likely to cause a decline in growth…

AstraZenecaEuropeGenericsMarkets & MarketingNeurologicalPatentsPharmaceuticalPricingSeroquel

US court turns down AstraZeneca FDA injunction; Teva debuts generic Seroquel in UK


In another setback for Anglo-Swedish drug major AstraZeneca in its fight to delay generic competition…

AstraZenecaEuropeGenericsLegalNeurologicalNorth AmericaPatentsPharmaceuticalRegulationSeroquelSeroquel XR

AstraZeneca in deal with Galapagos; view on Seroquel law suit


BioFocus and Argenta, service companies of Netherlands-based Galapagos (Euronext: GLPG), yesterday announced…

Argenta DiscoveryAstraZenecaBioFocusGalapagosLegalNeurologicalPharmaceuticalResearchRespiratory and PulmonarySeroquelSeroquel XR

AstraZeneca sues US FDA over Seroquel decision


Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced this morning that it has filed a law suit against…

AstraZenecaLegalNeurologicalNorth AmericaPharmaceuticalRegulationSeroquelSeroquel XR

AstraZeneca Seroquel petitions denied by US FDA


The US Food and Drug Administration had denied Citizen Petitions filed by Anglo-Swedish drug major AstraZeneca…

AstraZenecaSeroquelSeroquel XR

Back to top